The association of obesity and cervical cancer screening: a systematic review and meta-analysis
- PMID: 18997682
- PMCID: PMC3008358
- DOI: 10.1038/oby.2008.480
The association of obesity and cervical cancer screening: a systematic review and meta-analysis
Abstract
Obese women are at an increased risk of death from cervical cancer, but the explanation for this is unknown. Through our systematic review, we sought to determine whether obesity is associated with cervical cancer screening and whether this association differs by race. We identified original articles evaluating the relationship between body weight and Papanicolaou (Pap) testing in the United States through electronic (PubMed, CINAHL, and the Cochrane Library) and manual searching. We excluded studies in special populations or those not written in English. Two reviewers sequentially extracted study data and independently extracted quality using standardized forms. A total of 4,132 citations yielded 11 relevant studies. Ten studies suggested an inverse association between obesity and cervical cancer screening. Compared to women with a normal BMI, the combined odds ratios (95% CI) for Pap testing were 0.91 (0.80-1.03), 0.81 (0.70-0.93), 0.75 (0.64-0.88), and 0.62 (0.55-0.69) for the overweight and class I, class II, and class III obesity categories, respectively. Three out of four studies that presented the results by race found this held true for white women, but no study found this for black women. In conclusion, obese women are less likely to report being screened for cervical cancer than their lean counterparts, and this does not hold true for black women. Less screening may partly explain the higher cervical cancer mortality seen in obese white women.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c314/3008358/5e5d9c7f07c9/nihms-90371-f0001.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c314/3008358/50c6cc8d68fb/nihms-90371-f0002.gif)
Similar articles
-
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371. Health Technol Assess. 2022. PMID: 36321689 Free PMC article.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD007807. doi: 10.1002/14651858.CD007807.pub4. Cochrane Database Syst Rev. 2020. PMID: 32851663 Free PMC article.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 27;8:CD007807. doi: 10.1002/14651858.CD007807.pub4. PMID: 28752910 Free PMC article. Updated. Review.
Cited by
-
Diabetes and cancer: two diseases with obesity as a common risk factor.Diabetes Obes Metab. 2014 Feb;16(2):97-110. doi: 10.1111/dom.12124. Epub 2013 Jun 12. Diabetes Obes Metab. 2014. PMID: 23668396 Free PMC article. Review.
-
Doctor shopping by overweight and obese patients is associated with increased healthcare utilization.Obesity (Silver Spring). 2013 Jul;21(7):1328-34. doi: 10.1002/oby.20189. Epub 2013 May 13. Obesity (Silver Spring). 2013. PMID: 23671015 Free PMC article.
-
Inequalities in reported use of cervical screening in Estonia: results from cross-sectional studies in 2004-2020.BMC Womens Health. 2022 Dec 24;22(1):545. doi: 10.1186/s12905-022-02123-z. BMC Womens Health. 2022. PMID: 36566176 Free PMC article.
-
Current Therapeutic Approaches in Cervical Cancer Based on the Stage of the Disease: Is There Room for Improvement?Medicina (Kaunas). 2023 Jun 30;59(7):1229. doi: 10.3390/medicina59071229. Medicina (Kaunas). 2023. PMID: 37512041 Free PMC article. Review.
-
Patient Decisions Regarding Rescheduling Colonoscopies Postponed Due to the COVID-19 Pandemic.Dig Dis Sci. 2023 Dec;68(12):4339-4349. doi: 10.1007/s10620-023-08119-5. Epub 2023 Oct 4. Dig Dis Sci. 2023. PMID: 37794293
References
-
- Screening for cervical cancer: Recommendations and rationale. Jan, 2003. homepage on the Internet. Available from: http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.htm. - PubMed
-
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003 Apr 24;348(17):1625–38. - PubMed
-
- Amonkar MM, Madhavan S. Compliance rates and predictors of cancer screening recommendations among Appalachian women. J Health Care Poor Underserved. 2002 Nov;13(4):443–60. - PubMed